Maryna Derkach
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Maryna Derkach has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Arto Ohinmaa
School of Public Health, University of Alberta, Edmonton, Canada
1 shared publication - Fatima Al Sayah
Alberta PROMs and EQ-5D Research and Support Unit (APERSU), School of Public Health, University of Alberta, Edmonton, Canada
1 shared publication - Jeffrey A. Johnson
School of Public Health, University of Alberta, Edmonton, Canada
1 shared publication - Lawrence Walter Svenson
Alberta Health, Edmonton, Canada
1 shared publication
Latest Publications
- Open Access
- 13 June 2022
- Published by Springer Nature in Journal of Patient-Reported Outcomes
- Vol. 6 (1) , 1-13
Comparative performance of the EuroQol EQ-5D-5L and the CDC healthy days measures in assessing population health
Objectives: To examine the comparative performance of EuroQol EQ-5D-5L and Center for Disease Control Healthy Days measures in assessing population health. Methods: Using data from 2014 Alberta Community Health Survey, a cross-sectional population-based survey (N = 7559), conducted in Alberta, Canada, we examined construct validity of the measures as indicators of population health. Differences in EQ-5D-5L index score, visual analogue scale (EQ-VAS), and CDC unhealthy days index across socio-demographic subgroups were tested by Mann–Whitney and Kruskal–Wallis tests using known-groups approach. Results: EQ-5D-5L and CDC Healthy Days provided comparable assessments of population health in this sample. Both measures discriminated between subgroups defined by self-perceived health status, level of education, and material deprivation. The discriminative ability of CDC Healthy Days was limited in capturing variability in health among age groups compared to the EQ-5D-5L. Among participants who reported 0 unhealthy days, the proportion of those with level 3 problems in pain/discomfort varied from 1.1% for participants aged 18–24 to 19.2% for those over 75 years. Conclusions: EQ-5D-5L demonstrated better construct validity than CDC Healthy Days in assessing health in a population-based sample of adults.
- 13 June 2022
- Published by Springer Nature in Journal of Patient-Reported Outcomes
- Vol. 6 (1) , 1-13
Open AccessComparative performance of the EuroQol EQ-5D-5L and the CDC healthy days measures in assessing population health
Objectives: To examine the comparative performance of EuroQol EQ-5D-5L and Center for Disease Control Healthy Days measures in assessing population health. Methods: Using data from 2014 Alberta Community Health Survey, a cross-sectional population-based survey (N = 7559), conducted in Alberta, Canada, we examined construct validity of the measures as indicators of population health. Differences in EQ-5D-5L index score, visual analogue scale (EQ-VAS), and CDC unhealthy days index across socio-demographic subgroups were tested by Mann–Whitney and Kruskal–Wallis tests using known-groups approach. Results: EQ-5D-5L and CDC Healthy Days provided comparable assessments of population health in this sample. Both measures discriminated between subgroups defined by self-perceived health status, level of education, and material deprivation. The discriminative ability of CDC Healthy Days was limited in capturing variability in health among age groups compared to the EQ-5D-5L. Among participants who reported 0 unhealthy days, the proportion of those with level 3 problems in pain/discomfort varied from 1.1% for participants aged 18–24 to 19.2% for those over 75 years. Conclusions: EQ-5D-5L demonstrated better construct validity than CDC Healthy Days in assessing health in a population-based sample of adults.